Davis Polk partner Yasin Keshvargar discussed the uptick in biotech IPOs this year and the market outlook for the rest of 2026 with Law360. “The pipeline is really robust. There are…
On October 7, 2025, Davis Polk partner Yasin Keshvargar will be among the speakers at the 2025 Innovate Basel Conference. Yasin will speak on the “Current Trends in Pharma M&A,…
On May 13, 2025, Davis Polk partners David Bauer and Yasin Keshvargar will be among the speakers at L Suite’s Biotech Workshop, which will focus on emerging compliance challenges, evolving…
Davis Polk partner Yasin Keshvargar discussed the impact of tariffs on corporate disclosure trends with Law360.The article notes that approximately 584 U.S.-listed companies have mentioned…
Davis Polk partner Yasin Keshvargar discussed the recent uptick in capital markets deal activity in the biotech space and the outlook for the IPO market with the Financial Times.“There’s a…
Davis Polk partner Yasin Keshvargar was recently quoted in Law360 discussing the busy June IPO market. The article notes that Davis Polk worked on 23 IPOs in June, more than any other…
Law360 has named five Davis Polk partners among its 2021 Rising Stars:Yasin Keshvargar – Capital Markets (read the full profile)Angela Libby – Energy (read the full profile)Emily Roberts –…
The National Law Journal has named Davis Polk partner Yasin Keshvargar among its 2020 “Crisis Leadership Trailblazers.” Honorees represent individuals who have launched new initiatives to…
New York, NY, June 26, 2019 – Davis Polk has announced that Yang Chu, Hilary Dengel, Vanessa Jackson, Yasin Keshvargar, Angela Libby, Fiona Moran, Emily Roberts, Evan Rosen, Darren…
